Kemper Health & Wellness

03/17/2026

03/16/2026

A recent study presented at the San Antonio Breast Cancer Symposium offers reassurance to women diagnosed with a BRCA genetic mutation. There is data to support that one can still undergo hormone replacement therapy in order to retain a better quality of life.

Hormone therapy did not increase the breast cancer risk over 5 years among BRCA carriers who opted to use if after surgical menopause vs their p*ers who did not undergo replacement therapy.

Women who had undergone hysterectomy and used estrogen-only hormone therapy, breast cancer risk was actually REDUCED.

Guidelines recommend that women with BRCA mutations manage their high risk for ovarian cancer with surgical removal of the ovaries and fallopian tubes before age 40 for BRCA1 carriers and before age 45 for BRCA2 carriers.

The resulting surgical menopause can cause severe vasomotor symptoms-hot flashes, night sweats, urogenital symptoms such as frequent UTIs which can severely alter quality of life.

03/12/2026

Women! Listen up!

Those who start hormone replacement therapy within a year of menopause have a lower risk of developing osteoporosis.

Data was analyzed from more than 137,000 postmenopausal women younger than 60 years old. The early hormone replacement therapy group was defined as those women receiving therapy within the first year of diagnosis of menopause. They matched these women against those not receiving hormone treatment.

At 3 years, there were no statistically significance between groups. However at 5 years-it was evident that those receiving hormone replacement had less rates of being diagnosed with osteoporosis and less incidence of fractures.

03/10/2026

Guess you missed out! Last weekend Hana and I went to support our awesome Kemper Health and Wellness patient who puts on the entire Fort Wayne Home and Garden show! We got to get up close with some amazing butterflies and also got to do a meet and greet with some frisky skiing squirrels! Trio gave me an inner ear wet W***y and decided to mark and p*e on Hana to claim her as his own. 😂

03/09/2026

03/06/2026

This is why we are always yelling at our weight loss patients about taking their Vitamin D, iron supplements (or better yet, eating more iron rich foods) and B vitamins.

In a recent study published, over 450,000 people using GLP-1 medications for weight loss, 12.7% of the population had vitamin D deficiency. Diagnoses of muscle loss, B deficiencies, dehydration and mineral deficiencies like calcium zinc also occurred over time.)

Most users failed to meet recommended intakes for vitamin D, iron, calcium and protein.

We are always testing for these things and urging folks to consume at least 2 grams of protein per their body weight in kilograms.

Make sure you are getting in your nutrients!

03/05/2026

The internet and phones are down at the office for the rest of the day according to Comcast troubleshooting the area.

So if you all are trying to get through to us, we are here, just can't answer the phones. Please shoot us a portal message instead.

03/05/2026

Have Alzheimer's in your family and concerned about yourself in the future? Or did you play lots of sports in your life and suffered many concussions or head injuries? There is promising research and labs that have a great predictability to assess these things. We have the capability of testing these.

The combination of GFAP (glial fibrillary acidic protein), NfL (neurofilament light chain), and p-tau217 (phosphorylated tau at threonine 217) is emerging as a highly promising blood-based biomarker panel for the early detection and prediction of Alzheimer’s disease (AD). Each of these markers reflects a different aspect of the neurodegenerative process, and when measured together, they significantly enhance diagnostic accuracy.

🧠 1. GFAP (Glial Fibrillary Acidic Protein)
GFAP is an astrocytic protein—it’s released when astrocytes (a type of supportive brain cell) become reactive in response to brain injury or pathology.
Elevated GFAP levels indicate astrocyte activation and neuroinflammation, both of which occur early in Alzheimer’s, even before obvious cognitive symptoms.

🧬 2. NfL (Neurofilament Light Chain)
NfL is a neuronal cytoskeletal protein released into CSF and blood during axonal damage or neurodegeneration. Elevated levels reflect overall neuronal injury, not specific to Alzheimer’s but indicative of neurodegenerative processes. NfL rise helps distinguish neurodegeneration severity and track disease progression across multiple disorders (not just AD).

🧩 3. p-tau217 (Phosphorylated Tau at Threonine 217)
p-tau217 directly mirrors tau pathology, which is a hallmark of Alzheimer’s.
This phosphorylation site is particularly specific for Alzheimer’s-type tau aggregation, distinguishing it from other tauopathies. p-tau217 is strongly correlated with both amyloid and tau PET imaging, making it one of the best single plasma biomarkers for AD.

🧬 Combined Predictive Power: GFAP + NfL + p-tau217
Each biomarker captures a different biological process:
GFAP → early astrocyte reactivity and amyloid pathology
NfL → generalized neuronal injury
p-tau217 → specific Alzheimer’s tau pathology
When used together, they enable:

High sensitivity and specificity for identifying individuals with early Alzheimer’s pathology compared to controls or other dementias.

02/27/2026

You need to check out the totally awesome Fort Wayne Home Garden Show that starts February 26th- March 1st!

One of our spectacular Kemper Health & Wellness patients continues annually to put on this huge show tirelessly as a staple to the community that her family started over 50 years ago.

Instead of complaining about all the snow, come tiptoe through the tulips, (even purchase some!) pet some farm animals and pretend it's already spring.

https://www.facebook.com/FtWayneHomeGardenShow/

https://home-gardenshow.com/